Zhang Jian, Xu Wenjing, Li Chaochao, Meng Fanqi, Guan Yanjun, Liu Xiuzhi, Zhao Jie, Peng Jiang, Wang Yu
Beijing Key Lab of Regenerative Medicine in Orthopedics, Key Laboratory of Musculoskeletal Trauma and War Injuries PLA, Institute of Orthopedics, Chinese PLA General Hospital, Beijing, P.R. China.
Department of Spine Surgery, Peking University People's Hospital, Beijing, P.R. China.
Tissue Eng Part B Rev. 2022 Apr;28(2):393-404. doi: 10.1089/ten.TEB.2020.0370. Epub 2021 May 11.
Until now, there is no clear definition of microtissue; it usually refers to the microtissue formed by the aggregation of seed cells under the action of cell-cell or cell-extracellular matrix (ECM). Compared with traditional cell monolayer culture, cells are cultivated into a three-dimensional microstructure in a specific way. The microstructure characteristics of microtissue are similar to natural tissues and can promote cell proliferation and differentiation. Therefore, it has a broader range of biomedical applications in tissue engineering. The traditional tissue engineering strategy is to add high-density seed cells and biomolecules on a preformed scaffold to construct a tissue engineering graft. However, due to the destruction of the ECM of the cells cultured in a monolayer during the digestion process with trypsin, the uneven distribution of the cells in the scaffold, and the damage of various adverse factors after the cells are implanted in the scaffold, this strategy is often ineffective, and the subsequent applications still face challenges. This article reviews the latest researches of a new strategy-tissue engineering microtissue strategy; discuss several traditional construction methods, structure, and function optimization; and practical application of microtissue. The review aims to provide a reference for future research on tissue engineering microtissue. Impact statement The traditional tissue engineering strategies have several disadvantages, researchers have conducted extensive research on tissue engineering microtissues in recent years, and they make significant progress. Microtissue is a kind of microtissue with three-dimensional structure, its microstructure is similar to that of natural tissue. In addition, microtissue implantation can protect cells from mechanical interference, inflammation, and other adverse factors. Furthermore, it improves the survival rate of cells and the therapeutic effect of tissue-engineered grafts. However, the practical conditions, advantages, and disadvantages of tissue engineering microtissue have not been fully elucidated. The purpose of this review is to discuss the latest research progress of microtissue and provide a reference for future research.
到目前为止,微组织尚无明确的定义;它通常是指种子细胞在细胞-细胞或细胞-细胞外基质(ECM)作用下聚集形成的微组织。与传统的细胞单层培养相比,细胞以特定方式被培养成三维微观结构。微组织的微观结构特征与天然组织相似,能够促进细胞增殖和分化。因此,它在组织工程领域具有更广泛的生物医学应用。传统的组织工程策略是在预制支架上添加高密度的种子细胞和生物分子以构建组织工程移植物。然而,由于在用胰蛋白酶消化过程中单层培养的细胞的细胞外基质被破坏、细胞在支架中分布不均以及细胞植入支架后受到各种不利因素的损害,这种策略往往无效,后续应用仍面临挑战。本文综述了一种新策略——组织工程微组织策略的最新研究;讨论了几种传统的构建方法、结构和功能优化;以及微组织的实际应用。该综述旨在为未来组织工程微组织的研究提供参考。影响声明 传统的组织工程策略存在若干缺点,近年来研究人员对组织工程微组织进行了广泛研究,并取得了重大进展。微组织是一种具有三维结构的微组织,其微观结构与天然组织相似。此外,微组织植入可以保护细胞免受机械干扰、炎症等不利因素的影响。此外,它提高了细胞的存活率和组织工程移植物的治疗效果。然而,组织工程微组织的实际条件、优缺点尚未完全阐明。本综述的目的是讨论微组织的最新研究进展,并为未来研究提供参考。